BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33638049)

  • 1. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
    Duan M; Chi X; Xiao H; Liu X; Zhuang H
    Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
    Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
    World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
    Gao Y; Wang M; Liu X
    Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone.
    Ren S; Wang W; Lu J; Wang K; Ma L; Zheng Y; Zheng S; Chen X
    Front Immunol; 2022; 13():1035923. PubMed ID: 36389814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
    Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
    J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels.
    Xie Y; Yi W; Zhang L; Lu Y; Hao HX; Gao YJ; Ran CP; Lu HH; Chen QQ; Shen G; Wu SL; Chang M; Ping-Hu L; Liu RY; Sun L; Wan G; Li MH
    J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
    Assy N; Beniashvili Z; Djibre A; Nasser G; Grosovski M; Nseir W
    World J Gastroenterol; 2009 Jun; 15(24):3025-31. PubMed ID: 19554656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study.
    Wei S; Hu M; Chen H; Xie Q; Wang P; Li H; Peng J
    BMC Gastroenterol; 2022 Aug; 22(1):387. PubMed ID: 35978283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
    Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
    World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
    Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
    Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone.
    Wang J; Yan X; Zhu L; Liu J; Qiu Y; Li Y; Liu Y; Xue R; Zhan J; Jiang S; Geng Y; Wan Y; Li M; Mao M; Gao D; Yin S; Tong X; Xia J; Ding W; Chen Y; Li J; Zhu C; Huang R; Wu C
    Aliment Pharmacol Ther; 2023 Mar; 57(5):464-474. PubMed ID: 36324235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis between ICG-R15 and modified Scheuer score in liver tissues of patients with hepatitis B e antigen-positive/negative chronic hepatitis B].
    Zhang MM; Zhang SW; Hu X; Bao FY; Pei ZY; Liu YY; Ma AD; Zhang LY
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):565-570. PubMed ID: 34225432
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
    Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ
    Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
    Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between HBV viral load and severity of liver inflammation in patients with chronic hepatitis B virus infection].
    Xing TJ; Zhao KY; Li WT; Wang LJ; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):954-960. PubMed ID: 37872091
    [No Abstract]   [Full Text] [Related]  

  • 20. qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels.
    Gan Q; Huang Y; Zhu C; Zhao S; Fu H; Cai M; Wang J; Zhang C; Guo S; Cao Z; Xie Q
    Can J Gastroenterol Hepatol; 2022; 2022():8695196. PubMed ID: 35875362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.